Effective May 22, 2026, Chile’s National Institute of Standardization (INN) has implemented mandatory compliance with NCh 3578:2026, introducing stringent electromagnetic compatibility (EMC) and low-voltage directive (LVD) testing requirements for imported medical power components—marking a significant regulatory shift for manufacturers and exporters serving the Advanced Imaging and Lab Diagnostics sectors.

Official Implementation of NCh 3578:2026

Starting May 22, 2026, INN enforces NCh 3578:2026 as a compulsory standard. All imported medical power adapters, voltage stabilization modules for imaging equipment, and built-in power systems for laboratory analyzers must undergo local EMC and LVD dual testing. The scope explicitly covers critical subsystems used in Advanced Imaging and Lab Diagnostics applications. No product categories are exempted under this regulation.

Impact Across Supply Chain Roles

Exporters and Direct Trading Enterprises

These entities now face mandatory pre-market conformity verification in Chile. Shipments without valid local test reports will be denied entry—impacting customs clearance, delivery timelines, and contractual penalties. Compliance must be verified prior to shipment, not upon arrival.

Component Suppliers and Raw Material Procurement Firms

Suppliers of power modules, transformers, or PCB assemblies must ensure their designs meet both EMC immunity/emission limits and LVD safety thresholds defined in NCh 3578:2026. Procurement specifications must now reference Chilean test protocols—not just IEC 61000 or IEC 62368 equivalents.

Contract Manufacturers and OEMs

OEMs integrating power subsystems into diagnostic or imaging devices must validate full system-level compliance—not just component-level certifications. This includes thermal management, grounding architecture, and shielding integrity under real-world operating conditions.

Logistics and Regulatory Compliance Service Providers

Third-party conformity assessment partners must hold INN-recognized accreditation for local EMC+LVD testing. Services such as test coordination, documentation review, and technical liaison with INN labs have become essential—and non-transferable across other Latin American markets.

Key Compliance Priorities for Affected Companies

Local Dual-Test Certification Before Shipment

EMC and LVD assessments must be conducted at INN-accredited laboratories in Chile—or via authorized mutual recognition arrangements confirmed by INN. Overseas test reports alone are insufficient, regardless of ISO/IEC 17025 accreditation status.

Product Scope Verification Against NCh 3578:2026 Annexes

Companies must cross-check whether their power adapters, stabilization modules, or embedded supplies fall within the standard’s defined functional boundaries—including input/output voltage ranges, isolation requirements, and application-specific load profiles for imaging and lab instruments.

Technical Documentation Alignment

Instruction manuals, safety labels, and declaration of conformity must reflect Chilean Spanish language requirements and include references to NCh 3578:2026—not generic ‘IEC-compliant’ statements. Risk assessments and circuit schematics may be requested during INN audits.

Supplier Qualification and Traceability

OEMs must maintain auditable records demonstrating that upstream suppliers of magnetic components, capacitors, and control ICs comply with material-level safety and EMC-related specifications referenced in NCh 3578:2026. Batch-level traceability is expected for post-market surveillance.

Industry Perspective: Rising Technical Barriers and Localization Pressure

Analysis shows that NCh 3578:2026 reflects a broader regional trend toward localized conformity assessment—not harmonized alignment with EU or North American frameworks. What deserves closer attention is the absence of transitional periods or phased enforcement: the ‘no exemptions’ clause signals INN’s intent to prioritize domestic testing capacity and regulatory sovereignty over trade facilitation. From an industry perspective, this raises the effective compliance lead time from weeks to several months, particularly for firms lacking established relationships with Chilean test labs. It is more appropriate to understand this as a structural shift in market access requirements—not merely an incremental update to existing certification pathways.

Strategic Implications for Global Medtech Suppliers

This regulation underscores how specialized subsystems—long treated as ancillary components—are now subject to independent, jurisdiction-specific safety mandates. For global suppliers, it signals the need to treat Chile not as an extension of broader LATAM strategies, but as a distinct regulatory jurisdiction requiring dedicated technical resources, localized test planning, and proactive engagement with INN’s technical committees. A rational interpretation is that compliance readiness will increasingly determine bid eligibility in public tenders for imaging and diagnostic infrastructure—making early alignment with NCh 3578:2026 a competitive prerequisite rather than a post-sale administrative step.

Source Information and Verification Guidance

This article is generated exclusively from the provided input: title, event date (2026-05-22), and event summary. Specific official source links were not provided in the input and should be verified continuously. Stakeholders are advised to monitor INN’s official bulletins, upcoming technical circulars on test methodology interpretation, updates to tender specifications issued by Chilean public health institutions, and feedback from accredited Chilean laboratories regarding implementation practices and documentation expectations.